11,247
Total Claims
$1.7M
Drug Cost
617
Beneficiaries
$2,726
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-96%
Opioid rate vs peers
0.1% vs 2.2% avg
+93%
Cost per patient vs peers
$2,726 vs $1,411 avg
+38%
Brand preference vs peers
14.6% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
11
Opioid Claims
$53
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
85% generic
Brand: 1,605 claims · $1.4M
Generic: 9,358 claims · $273K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 131 | $225K |
| Empagliflozin | 143 | $183K |
| Sitagliptin Phosphate | 118 | $137K |
| Linagliptin | 134 | $134K |
| Apixaban | 69 | $78K |
| Metformin Hcl | 14 | $71K |
| Semaglutide | 35 | $65K |
| Insulin Aspart | 57 | $60K |
| Dapagliflozin Propanediol | 26 | $39K |
| Sitagliptin Phos/Metformin Hcl | 32 | $34K |
| Insulin Glargine,hum.Rec.Anlog | 65 | $34K |
| Rivaroxaban | 31 | $33K |
| Budesonide/Formoterol Fumarate | 53 | $28K |
| Icosapent Ethyl | 44 | $27K |
| Insulin Glargine,hum.Rec.Anlog | 47 | $27K |
Prescribing Profile
Patient Profile
70
Avg Age
60%
Female
1.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data